Smiling woman sitting in front of green wall at AlkermesSmiling woman sitting in front of green wall at AlkermesBlue Triangle graphic

News and Events

Sharing Stories of
Patients, Employees
and Communities

Explore Our Stories

Featured News

July 17, 2024

Alkermes to Report Second Quarter Financial Results on July 24, 2024

Read more

June 03, 2024

Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024

Read more

May 29, 2024

Alkermes to Participate in Two Upcoming Investor Conferences

Read more

See all press releases

Our Commitment to Responsibility

Corporate responsibility has always played a central role in our business and has proven even more critical in recent years as we navigated pressing public health and societal issues– a dynamic global pandemic, systemic racism in the U.S. and around the world, and a worsening climate change crisis. Guided by our purpose and values, we took actions to respond to these critical issues, while sharpening our focus on scientific and business excellence in our efforts to help people living with complex and difficult-to-treat diseases. Our most recent Corporate Responsibility Report expounds on these efforts.

Corporate Responsibility reports   

Our Stories


Each endeavor at Alkermes starts with collaboration and our shared commitment to make a difference for patients and our communitiesThese stories – which highlight our people, science and innovation, and leadership perspectives – showcase just a subset of what makes us proud to be part of Alkermes. Visit our full gallery of stories by clicking on the link below.

Pride@Work Logo

Sharing Reflections on Pride Month


Our Pride@Work Executive Sponsors are committed to supporting the LGBTQ+ community.

Read More

Perspectives on Memorial Day


Hear from members of Operation Salute, our ERG for Veterans, as they reflect on Memorial Day.

Read More

Alkermes operation salute employee resource group logo

Susan Colby

Honoring our 2024 HBA Rising Star


We’re proud to recognize Susan Colby, Director of Human Resources, as our 2024 HBA Rising Star.

Read More

Media Resources

Company Description

Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.

Media Inquiries

Email our media team


Company Logos

Download logos


Company Photo

Download photo


Corporate Fact Sheet

Download fact sheet 


Follow us on our social channels   

blue triangle graphic

Statements and Positions

The idea that a corporation can play a profoundly positive role in society is central to our vision. We believe it is our obligation to voice our beliefs about issues that impact the patients we serve and the communities in which we live and work.




Company Statement on the Invasion of Ukraine






Read our statement

Systemic Racism and Violence

Read our statement